Beijing Tiantan Biological Products Hits Day Low Amid Price Pressure at CNY 15.51

Beijing Tiantan Biological Products Corp. has experienced a notable decline today, with the stock dropping by 3.0% and reaching an intraday low of CNY 15.51. This performance contrasts with the China Shanghai Composite, which fell by 1.24% on the same day. Over the past week, the stock has decreased by 3.6%, slightly underperforming the composite index, which declined by 3.38%. In terms of longer-term performance, Beijing Tiantan has faced significant challenges, with a year-to-date decline of 5.08% and a staggering 24.12% drop over the past year. The stock's performance over three years shows a decrease of 37.64%, while the five-year performance reflects a decline of 52.41%. Financial metrics indicate that the company has struggled with net sales, which fell by 24.69%, and operating cash flow has reached a low of CNY -324.97 million. The debt-equity ratio stands at -14.54%, highlighting financial pressures. Despite these challenges, the company maintains a market capitalization of CNY 32,231 million and a price-to-earnings ratio of 19.00.